Articles by Daniel Marsh
P&G Acquires Thorne for $3.8B to Bolster Health Care Growth
P&G (PG) buys Thorne for $3.8 billion, a 5.85x sales multiple, to accelerate health care growth. Thorne accounts for 5.2% of P&G's health care revenue.
Bluejay Diagnostics Stock Jumps 47% Premarket Despite Warrant Hurdles
Bluejay Diagnostics (BJDX) shares soared 47% premarket, but the rally leaves the stock below the warrant strike price, complicating financing plans.
Amazon's $71B Wipeout: Bezos Sale Plan Clouds AWS Growth
Amazon shares dropped 2.32%, erasing $71B in market value, as Jeff Bezos' planned sale of 15M shares offset strong AWS growth.
Autonomix Medical Stock Rockets 434% on Delayed Patent Disclosure
Autonomix Medical (AMIX) shares skyrocketed 434% on Tuesday following a delayed patent announcement. The stock later fell 37.7% in premarket trading.
Intel's 10.8% Surge Masks Foundry Losses: Recovery Still Unproven
Intel shares surged 10.8% on Tuesday, but the rally masks persistent foundry losses. External customers contribute just 5.1% of foundry revenue, and the division lost $2.1B in Q2. AMD fell premarket despite strong results.
Nokia Shares Rebound on AI Orders, Focus Shifts to Conversion
Nokia's shares rebound as AI orders surge to €3.8B, but the key test is converting these orders into revenue without eroding margins.
Student Loan Cap Narrows Private Lender Market
New federal loan caps reduce the private lending market to 17.4% of graduate borrowers, reshaping opportunities for SLM, SOFI, and NAVI.
Global Markets Rally on Hormuz Hopes; Glencore Eyes Australia Listing
Markets rallied on Hormuz hopes; Glencore targets Australia listing; SpaceX and AMD slide on AI spending concerns; Manipal IPO jumps 11%.



